A comparison of the effect of short-acting and long-acting cloxacillin-based dry-cow therapy on somatic cell counts after calving in cows also given internal teat sealants

AIM: To compare, in cows treated with an internal teat sealant, the effect of short-acting and long-acting cloxacillin-based dry-cow therapy on somatic cell counts (SCC) after calving.

METHODS: Cows from a spring-calving, pasture-based dairy farm in the Manawatu-Whanganui region of New Zealand were randomly allocated to receive either a short-acting cloxacillin and ampicillin dry-cow therapy and internal teat sealant (n=291) or a long-acting cloxacillin and ampicillin dry-cow therapy and internal teat sealant (n=288) at the end of lactation. Cows were managed on-farm with routine husbandry procedures through the dry period and following calving. A multivariable logistic regression model was used to determine the association between length of action of dry-cow therapy and the proportion of cows with a SCC >150,000?cells/mL at the first herd test after calving.

RESULTS: Age of cow, mean SCC for the preceding season and interval from calving to the first post-calving herd test were all associated with the proportion of cows with an individual SCC >150,000?cells/mL at the first herd test (p<0.001) Treatment with the short-acting dry-cow therapy was not associated with decreased odds of cows having a SCC >150,000?cells/mL at the first herd test compared with treatment with long-acting dry-cow therapy (OR=0.724; 95% CI=0.40–1.30).

CONCLUSIONS AND CLINICAL RELEVANCE: In this herd, which routinely used internal teat sealants, the use of short-acting cloxacillin-based dry-cow therapy did not result in an increased proportion of cows with elevated SSC post-calving. This was a single farm, single year study but indicates that in this herd, changing from a long-acting to a short-acting antimicrobial may have no impact on the prevalence of subclinical mastitis.     

Comparison of cephalonium alone and in combination with an internal teat sealant for dry cow therapy in seasonally calving dairy cows

AIM: To assess the effect of combining an internal teat sealant (ITS) and a long-acting cephalonium-based dry cow therapy (DCT) on the prevalence of cows with a somatic cell count (SCC) >150,000 cells/mL 60–80 days after calving, and the incidence of clinical mastitis diagnosed by farm staff in the first 100 days after calving.

METHODS: Cows from a spring-calving, pasture-based, dairy farm in the South Canterbury region of New Zealand were randomly allocated to receive cephalonium DCT (n=289) or cephalonium and internal teat sealant (n=304) at the end of lactation. Cows were inspected twice daily by farm staff during the dry period and following calving for signs of mastitis. Individual SCC were determined from herd tests conducted in the previous lactation and following calving. Logistic regression models were used to determine relationships with the prevalence of cows with a SCC >150,000 cells/mL after calving, and survival analysis was used to model time to the first case of clinical mastitis following calving at the cow and quarter level.

RESULTS: The OR for a cow with a SCC >150,000 cells/mL after calving, including age and individual SCC in the preceding lactation in the model, was 0.53 (95% CI=0.32–0.89) for cows treated with combination therapy compared to cows receiving cephalonium (p=0.017). At the cow level, including age and preceding SCC in the model, the hazard ratio for diagnosis of clinical mastitis by farm staff in the first 100 days of lactation was 0.60 (95% CI=0.39–0.98) for cows treated with combination therapy compared to cows receiving cephalonium (p=0.04). At the quarter level, the hazard ratio for diagnosis of clinical mastitis, with age included in the model, was 0.41 (95% CI=0.23–0.74) for the combination therapy compared to cephalonium alone (p<0.001).

CONCLUSIONS: The combination of internal teat sealant and cephalonium DCT was more effective than cephalonium alone at reducing clinical mastitis diagnosed by farm staff in the 100 days after calving, and the prevalence of cows with a SCC >150,000 cells/mL 60–80 days after calving.

CLINICAL RELEVANCE: This study adds to the evidence that the prevention of intra mammary infections throughout the dry period and up to calving by using combination therapy is important in reducing the incidence of farmer-diagnosed clinical mastitis and prevalence of cows with a SCC >150,000 cells/mL 60–80 days after calving.     

奶牛隐性乳房炎的调查分析

采用体细胞计数(SCC)法对杨凌某奶牛场中60头不同胎次和泌乳时间奶牛隐性乳房炎进行检测,对引起乳房炎的可能诱因进行调查分析,研究该场奶牛隐性乳房炎的发病规律,为本病的防控提供参考。结果表明,受检奶牛隐性乳房炎的检出率为43.3%。1胎～2胎奶牛隐性乳房炎检出率为40.0%,3胎～4胎为46.7%,隐性乳房炎的检出率有随胎次增加而升高的趋势;泌乳时间少于200 d的泌乳牛隐性乳房炎检出率为27.6%,200 d～300 d的为36.4%,300 d～400 d的为41.7%,超过400 d的为50.0%,提示奶牛隐性乳房炎有随泌乳期升高的趋势。本调查显示,奶牛隐性乳房炎的发生与胎次和泌乳时间有显著的相关性,饲养管理和卫生条件是乳房炎发生的重要诱因。     

Teat canal closure in non-lactating heifers and its association with udder health in the consecutive lactation

Prevention of heifer mastitis is a key element in preventing mastitis. Since pathogenesis of heifer mastitis is not fully understood yet, combating it is arduous. The goal of this study was to examine whether the premature loss of the keratin plug of the teat canal represents an important risk factor for the development of heifer mastitis. 84 dairy heifers (German Holstein) from six high-yielding dairy herds in Northern Germany were examined between March 2005 and June 2006. Each quarter was examined clinically at least three times before calving. If the teat canal of a quarter was open, secretion samples were collected for bacteriological analysis. After calving, four quarter samples were collected during the first lactation. A rapid increase of the proportion of open teat canals was detected in the preparturition period. No teat canals were open till 80 days before parturition, while 60% of the teat canals were open at 60 days before parturition. A time-scheduled infection pattern was observed: during the days 90-61, 60-31, and 30-0 before calving, skin inhabitants (coagulase-negative staphylococci, coryneform bacteria), cow-related, and environment-related microorganisms prevailed, respectively. A total of 77% of intramammary infections encountered at parturition had established previously. No significant association between the duration of open teat canals before calving and the udder health post partum was found. However, the incidence of clinical mastitis during first lactation was influenced largely by the duration of infection ante partum and the mastitis pathogen involved. This study shows that a high proportion of teat canals already opens several months before calving and that opening of the teat canal before calving is an important factor in the aetiology of heifer mastitis.     

Udder health at a Swedish research farm with both organic and conventional dairy cow management

Our aim was to compare udder health in groups of organically and conventionally managed cows, using data from a longitudinal study in a Swedish dairy-research farm. Management of the groups was identical except for feed composition and the feeding regimen. Our dataset included all lactating cows calving from 1 September 1990 to 31 August 2001 (145 organically and 151 conventionally managed cows). Udder health was assessed by the geometric average somatic-cell count (SCC) within 150 days after calving, by the number of monthly SCC tests >200,000 cells/ml within 150 days after calving and by presence of lactations with veterinary-treated cases of clinical mastitis. The effect of animal group was analysed by multivariable linear, Poisson and logistic-regression models, controlling for factors such as lactation number, breed, year, season and milk yield. The groups did not differ in any measure of udder health. We had power to rule out differences of at least 33,000 cells/ml in the geometric average somatic-cell count, an incidence rate ratio of 0.65 in the incidence of high-SCC milk-testing occasions, and an odds ratio of 0.43 in veterinary treated cases of mastitis.     

Antioxidant enzymes and somatic cell count in dairy cows fed with organic source of zinc,copper and selenium

The objectives of this study were to evaluate the effects of dietary organic sources of zinc (Zn), copper (Cu) and selenium (Se) for dairy cows on somatic cell count (SCC), occurrence of subclinical mastitis, number of clinical mastitis cases and concentration of superoxide dismutase (CuZnSOD), glutathione peroxidase (GSH-Px) and ceruloplasmin (CP). Nineteen dairy cows, with confirmed pregnancy, were selected by body weight, body condition score (BCS), number of lactation, and milk yield in previous lactation, and randomly distributed among two groups, one to receive organic (n = 9) and the other the inorganic (n = 10) source of Zn, Cu and Se. Diets were formulated to meet the nutritional requirements of animals from 60 days before the expected date of calving up to 80 days of lactation. Blood samples were collected at − 60, − 21, 1, 21, 40 and 80 days in relation to the expected date of calving for analysis of CuZnSOD, GSH-Px and CP concentration. Milk samples for SCC determination were collected weekly after 15 days of lactation, also at day 1 and 7 and when a clinical case was diagnosed for microbiological culture. The number of new and total cases of subclinical mastitis was lower for the group of cows fed with organic sources of Zn, Cu and Se compared to animals receiving inorganic sources. Average SCC during the first 80 days of lactation tended to be lower for the group fed with organic Zn, Cu and Se. Feeding organic Zn, Cu and Se did not alter the concentration of CuZnSOD, GSH-Px and CP.     

Investigation of the association between the interval from internal teat sealant administration to calving and early lactation clinical mastitis in New Zealand dairy heifers

AIMS: To examine the association between the interval from internal teat sealant (ITS) administration to calving and the incidence of farmer-recorded clinical mastitis in the first 30 days of lactation in pasture-based dairy heifers.

METHODS: Heifers that were administered an ITS by a single veterinary business in the South Island of New Zealand over the winter of 2014 were enrolled in a cross-sectional observational study. ITS was administered to all heifers on each participating farm on a single calendar day. The dates of calving and farmer-diagnosed clinical mastitis were recorded by farm staff. The interval from ITS administration to calving was categorised into four approximately evenly sized groups: <35, 35–48, 49–69 and >69 days. The quartile of the farm’s calving period in which each heifer calved was also investigated as a potential confounding variable. A hierarchical logistic regression model was constructed to determine the association between the interval from ITS administration to calving with the odds of clinical mastitis in the first 30 days of lactation.

RESULTS: Analysis was performed on 7,126 eligible heifers from 31 farms, with ITS administered between 9 May and 11 July 2014. The mean interval from ITS administration to calving was 52.9 (SD 24.4, min 1, max 137) days. Clinical mastitis was diagnosed in 420/7,126 (5.9 (95% CI=5.4–6.5)%) heifers between calving and day 30 of lactation. In the final multivariable model, which included calving period quartile, interval from ITS administration to calving was not associated with the odds of clinical mastitis (p=0.516). Compared to an interval from ITS administration to calving of <35 days, the adjusted OR of clinical mastitis for intervals of 35–48, 49–69 and >69 days were 0.83 (95% CI=0.59–1.17), 0.71 (95% CI=0.45–1.11) and 0.68 (95% CI=0.36–1.29), respectively.

CONCLUSIONS AND CLINICAL RELEVANCE: Within the range of intervals from ITS administration to calving observed in this study, there was no association with the odds of clinical mastitis in the first 30 days of lactation in dairy heifers. This study suggests that veterinary clinics may be able to extend their ITS administration service and treat dairy heifers earlier than the current recommendation of approximately 4 weeks before the planned start of calving.     

Production effects related to mastitis and mastitis economics in dairy cattle herds

Mastitis is the most prevalent production disease in dairy herds world-wide and is responsible for several production effects. Milk yield and composition can be affected by a more or less severe short-term depression and, in case of no cure, by a long-acting effect, and, sometimes, an overlapping effect to the next lactation. Summary values in the literature for losses of milk production were proposed at 375 kg for a clinical case (5% at the lactation level) and at 0.5 kg per 2-fold increase of crude SCC of a cow. Due to the withdrawal period after treatment, composition changes in milk can almost be neglected in economic calculations. Lethality rate for clinical mastitis is very low on the average, while anticipated culling occurs more frequently after clinical and subclinical mastitis (relative risk between 1.5 and 5.0). The economics of mastitis needs to be addressed at the farm level and, per se, depends on local and regional epidemiological, managerial and economic conditions. To assess the direct economic impact of mastitis, costs (i.e. extra resource use) and losses (i.e. reduced revenues) have to be aggregated. To support decision making for udder health control, it is necessary to use a marginal approach, based on the comparison of the losses avoided and the additional costs of modified plans, compared to the existing ones.     

我国规模牛场奶牛个体生鲜乳体细胞数水平及影响因素探析

本研究旨在探析我国规模奶牛场奶牛个体生鲜乳体细胞数（SCC）的水平、分布和影响因素。利用SAS9.0的GLM模型,统计分析覆盖16个省（市、区）,33个规模奶牛场,23 351头中国荷斯坦牛,从2007年至2009年连续3年的225 775条奶牛个体生鲜乳SCC检测记录。结果表明：奶牛个体生鲜乳SCC的总体均值为48×104cell/mL,标准差为117×104cell/mL,个体生鲜乳SCC波动范围较大;其中,77.9%的奶牛个体,其生鲜乳SCC小于50×104cell/mL,对群体混合样生鲜乳SCC的影响系数为0.26;11.3%的奶牛个体,其生鲜乳SCC介于50×104～100×104cell/mL之间,乳房处于隐性感染状态,对群体混合样生鲜乳SCC的影响系数为0.16;10.8%的奶牛个体,生鲜乳SCC大于100×104cell/mL,理论上乳房处于临床感染状态,对群体混合样生鲜乳SCC的影响系数为0.58。奶牛个体生鲜乳体细胞数评分（SCS）呈正态分布,与奶牛个体因素（产奶量、乳脂率、乳蛋白含量、胎次和泌乳阶段）和环境因素（泌乳月份、泌乳季节）差异极显著（P〈0.01）,与奶牛养殖区域、奶牛场差异不显著（P〉0.05）。我国规模奶牛场奶牛个体生鲜乳SCC主要在50×104cell/mL以下,依据影响参数能实现对生鲜乳SCC水平的调控。     

Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle

The effect of an autogenous vaccine against Staphylococcus aureus on S. aureus prevalence and mastitis, as well as on somatic cell count (SCC), was studied in a dairy herd with a high prevalence of S. aureus. The vaccination group (n = 35; 22 cows and 13 heifers) and the control group (n = 36; 23 cows and 13 heifers) received the vaccine or a placebo, respectively, according to the following protocol: all animals: basic immunization (twice, 3 weeks apart); cows: booster dose at the time of drying off, 5 and 2 weeks before calculated calving date; heifers: booster dose 2 and 5 weeks before calculated calving date. The vaccine or the placebo was administered subcutaneously in the area of the supramammary lymph nodes. Quarter milk samples were collected monthly and subjected to SCC and bacteriological evaluation. At this time, the animals were also checked for signs of clinical mastitis. Non-clinical S. aureus mastitis diagnoses were based on udder quarter SCC and a positive S. aureus culture. In order to compare the SCC in individual whole milk samples, records from the monthly milk quality testing were evaluated. Cow and udder quarter prevalence of S. aureus intramammary infections calculated for the experimental animals and quarters, respectively, did not differ between groups. However, during the lactation period following the boostcr dose, the prevalence of S. aureus increased in both groups (P < 0.05). The cumulative incidence of various mastitis diagnoses (clinical, subclinical, latent infection) due to S. aureus on an animal basis did not differ between groups. On an udder quarter basis, the cumulative incidence of subclinical mastitis was higher in vaccinated animals than in control animals (33.8 versus 26.0%; P < 0.05). This was mainly due to a higher cumulative incidence of subclinical mastitis in vaccinated than control heifers. The SCC in composite milk samples did not differ between groups, but increased as lactation progressed. The herd prevalence of S. aureus differed considerably throughout the study period, but declined consistently to below 10% at the end of the study period. Recent herd checks revealed a prevalence of S aureus infections of < 5%. It is concluded that the autogenous bacterin tested in this study did not have the desired effect on the prevalence of S. aureus infections and mastitis or SCC. The decline in S. aureus prevalence was very probably due to other factors than specific immunization against S. aureus.     

Udder health and risk factors for subclinical mastitis in organic dairy farms in Switzerland

A study was performed in 1997 to estimate the prevalence and to investigate the etiology of subclinical mastitis in Swiss dairy herds managed under guidelines of controlled organic farming. It was planned as a longitudinal study over a period of 1 year and included a stratified random sample of 152 certified organic farms and 1907 cows. Two farm visits (the first from June to October when cows were on pasture, the second from January to March when cows were confined to barns) were performed on each farm. At each visit, farm management and individual-cow data (with emphasis on milking procedures and udder sanitation) were recorded. California mastitis tests (CMTs) were performed on each udder quarter of all cows in lactation. Milk samples with CMT >1+ were submitted for somatic cell counting (SCC), bacteriological examination and to test for antibiotic susceptibility. The SCC and germ-cell counts of monthly bulk-tank milk samples were available through Dairy Inspection and Advisory Services and milk production data of 567 herd-book cows were available from breeding associations. Possible individual and environmental predictors of subclinical mastitis were identified using logistic models adjusted for clustering of the data at herd and cow levels. Data were analyzed separately for cows from 7 to 100 and from 101 to 305 days post partum. Prevalences of subclinical mastitis at the quarter level were 21.2% for lactation period 7–100 days and 34.5% for 101–305 days post partum. The geometric mean SCC in bulk-tank milk samples was 85.6×10³ cells/ml. Samples at 7–100 and 101–305 days post partum were positive for Staphylococcus aureus in 16.0 and 7.4%, for coagulase-negative Staphylococci in 51.5 and 50.6%, for Streptococcus agalactiae in 0.0 and 0.8%, for other Streptococci in 19.4 and 15.6%, for E. coli in 1.0 and 0.4%, and for Corynebacterium bovis in 25.7 and 45.1%, respectively. Risks of subclinical mastitis increased significantly with increasing days post partum and advancing age of cow. Cows that were sampled when staying in alpine dairies had considerably higher risks of subclinical mastitis than cows staying in home barns. Significantly lower risks of subclinical mastitis were observed in farms where CMT was performed regularly as a control measure. Bacteria in milk from cows with mastitis exhibited antibiotic resistance at a comparable frequency as found previously in conventional farms.     

Efficacy of blanket treatment of cows and heifers with an internal teat sealant in reducing the risk of mastitis in dairy cattle calving on pasture

AIM: To evaluate the benefit of blanket treatment of all milking cows at drying-off and all replacement heifers one month prior to the planned start of mating with an internal teat sealant on the incidence of mastitis, and somatic cell counts (SCC), postpartum in a 650-cow herd with a mastitis incidence in early lactation of 15% in cows and 26% in heifers. METHODS: Prior to drying-off, lactating cattle were divided on the basis of SCC and mastitis history. Cattle with records of individual SCC >150,000 cells/ml or mastitis in the previous lactation were treated with a cloxacillin-based dry-cow therapy (DCT), while the remaining cattle received no antibiotics. Cattle in each of the two groups were then randomly assigned to receive either an internal teat sealant or no further treatment. Additionally, one month prior to the planned start of calving the rising 2-year-old heifers were also randomly assigned to receive either an internal teat sealant or no treatment. All clinical mastitis cases were recorded for the first 10 weeks after the start of calving, while SCC were measured on three occasions during the subsequent lactation. RESULTS: Data were available from 466 cows and 206 heifers; treatment with the internal teat sealant significantly reduced the incidence of mastitis in both groups. For cows, the reduced risk of mastitis due to treatment with the teat sealant was not significantly different between cows, which, based on their mastitis history, required dry-cow antibiotics and those which did not. There was no effect of teat sealant on the mean SCC of any group at any time-point. CONCLUSIONS: On this farm, treatment of all cows and heifers prior to parturition with an internal teat sealant significantly reduced the risk of clinical mastitis. The benefits of an internal teat sealant were the same when used in combination with antibiotics in cows with a history of mastitis as when used alone in cows with no such history. CLINICAL RELEVANCE: These data support the proposition that blanket treatment with an internal teat sealant of all cows due to enter the milking herd can be a useful method of mastitis control. They also suggest that combined therapy with dry-cow antibiotics and internal teat sealants can be beneficial under New Zealand conditions. More detailed research on more farms in more areas of New Zealand is required to confirm these suggestions.     

Evaluation of the on-line electrical conductivity of milk in mastitic dairy cows

Mastitis is a persistent, inflammatory reaction of the udder tissue, which entails a decline in potassium, and is also responsible for a higher somatic cell count (SCC) and electrical conductivity (EC) of milk. The measurement of EC is an indirect, rapid method to detect subclinical mastitis from milk. The aim of this study was to analyse the EC of milk throughout the lactation, around the day of mastitis detection, and also to estimate its heritability based on data from a large-scale dairy farm. Shortly after calving the EC value generally decreases; however, it was discovered that from the thirteenth week onwards, substantial differences arise between the mastitic and healthy groups of cows. The authors observed a significant (P < 0.001) increase in EC before the detection of clinical mastitis. This higher value (around 11 mS) persisted for 4 days, then it gradually returned to the normal level. The EC of milk from daughters sired by different bulls responded differently in case of mastitis. The heritability of EC seems to be high (h2 = 0.56). Therefore, the EC trait can be a beneficial indicator in detecting mastitis and should be considered in sire selection.     

初产牛乳腺炎研究进展

奶牛乳腺炎是由多种因素引起的严重影响奶牛业发展的重要疾病,初产牛临床和亚临床乳腺炎的流行和发病率,尤其在泌乳初期,均高于经产母牛.初产牛与经产牛的流行病学和危险因素不尽相同,为更加有效地控制初产牛乳腺炎,必须对初产牛乳腺炎进行深入系统的研究.论文重点论述了初产牛产前和产后临床、亚临床乳腺炎患病率和发病率,乳腺炎的致病因素,病原和诊断技术,介绍了国内外初产牛乳腺炎兽医防治、抗病育种等方面的研究成果.     

拜益生对奶牛隐性乳房炎、产奶量和乳品质的影响报告

[目的]为了研究拜益生对奶牛隐性乳房炎的预防作用及对奶牛产奶量和乳品质的影响。[方法]选择100头荷斯坦奶牛,随机分成10组,每组10头,其中5组为实验组,5组为对照组。从产前7d开始至产后60d,实验组每天每头牛添加拜益生40g,其余饲养管理与对照组完全一致。每15d测定一次产奶量,每个月测定一次DHI。[结果]表明:实验组日均产奶量与对照组比较,提高1.84～2.28kg/头.d-1,差异显著(P0.05);产后第30d,实验组牛奶的乳脂率和乳蛋白率比对照组分别提高0.4%、0.37%,差异极显著(P0.01);与对照组比,总固体率提高0.83%,体细胞数降低15.64万/mL,差异均显著(P0.05);产后第60d,实验组牛奶的乳脂率提高0.27%,体细胞数降低16.79万/mL,差异显著(P0.05),乳蛋白率和总固体较对照组均有不同程度的提高,但不显著。[结论]拜益生对提高奶牛的产奶量、改善牛奶品质和预防奶牛隐性乳房炎有积极的作用。     

Subclinical mastitis in ewes and its effect on lamb performance.

Two studies were conducted to 1) assess the effectiveness of the California mastitis test (CMT) relative to direct microscopic somatic cell count (DMSCC) and(or) somatic cell count (SCC) procedures for detecting subclinical mastitis in ewes, 2) determine the incidence of subclinical mastitis based on repeated or single sample measures and organisms associated with the inflammation, and 3) assess the relationship between milk quality measures and lamb performance. The relationship between DMSCC and SCC scores was significant (P less than .01); 90% of the variation in DMSCC scores was accounted for by SCC scores. In contrast, CMT scores accounted for only 26% of the variation in DMSCC and 30 to 34% of the variation in SCC scores. Incidence of inflammation varied from 17 to 50% of ewes tested, depending on the study and the method of assessment. Staphylococcus species were cultured from 14/41 samples tested, with cultures of Streptococcus species (3/41) and Micrococcus species (1/41) also present. The effect of subclinical mastitis in ewes on lamb performance was minimal when assessed by regressing lamb weights on subclinical mastitis and milk quality scores. In conclusion, growth performance of lambs in a management system where they had access to supplemental feed was not influenced by the quality of milk produced by ewes, or by the degree of subclinical mastitic inflammation present when they suckled.     

Therapeutic effects of systemic or intramammary antimicrobial treatment of bovine subclinical mastitis during lactation

The short- and long-term treatment efficacy of administrating penicillin for bovine subclinical mastitis during lactation when using intramuscular (IM; 9.5 mg [15,000 IU]/kg bodyweight of benzyl penicillin potassium) injections twice daily for 5 days, or intramammary (IMM; 0.3g [300,000 IU] penethamate hydroiodide) administration once daily for 5 days was compared with a control group receiving no treatment. One hundred and twenty-six cows met the inclusion criteria, which were lack of clinical symptoms, no recent treatment with antimicrobials, and findings of penicillin-sensitive Staphylococcus aureus, Streptococcus dysgalactiae, or Streptococcus uberis in combination with an inflammatory reaction. At follow-up 42-58 days after treatment, the proportion of cows negative for the original infection was significantly higher in IM and IMM groups compared to controls, but the difference between antimicrobial treatment groups was not significant. The udder quarter milk somatic cell count (SCC) was significantly lower at follow-up in IM and IMM groups than in controls, but milk production did not differ between treatments. The culling rate during the 10-month period following treatment was significantly higher in the group treated with IMM penicillin than in the other two groups, but the risk of new mastitis treatments within 10 months did not differ between the three groups. The cure rate was significantly affected by lactation number (lower in older cows), breed (lower in the Swedish Holstein breed), pathogen (lower for S. aureus), and pre-treatment SCC (higher for above average SCC). In conclusion, beneficial long-term effects of antimicrobial treatment during lactation of subclinical mastitis caused by S. aureus, Str. dysgalactiae or Str. uberis were not found in the present study.     

Subclinical mastitis causes alterations in nitric oxide, total oxidant and antioxidant capacity in cow milk

The aim of this study was to investigate total antioxidant (TAC), and oxidant capacity (TOC) and nitric oxide (NO) levels in milk of cows with subclinical mastitis. Brown Swiss and Holstein breed cows were screened with California Mastitis Test (CMT) to determine mammary glands with subclinical mastitis. Moreover, somatic cell counts (SCC) were determined electronically in all milk samples. Mammary quarters were classified as healthy (n = 25) or subclinical mastitis (n = 35) based on CMT scores and somatic cell count (SCC: ?200,000/ml or >200,000/ml) in milk. Nitric oxide, TOC and SCC levels were significantly higher (p < 0.001, p < 0.005 and p < 0.001, respectively) in milk from mammary quarters with subclinical mastitis compared to those from healthy mammary quarters. In conclusion, subclinical mastitis results in higher NO concentrations, TOC and SCC, and NO and TOC were positively correlated with SCC. Moreover, alterations in NO levels and TOC in milk could be used as an alternative diagnostic tool to screen for subclinical mastitis.     

荷斯坦牛产后前60 d患隐性乳房炎次数对各泌乳月SCS的影响

荷斯坦牛产后前60 d患隐性乳房炎（SCM）次数反映了泌乳牛产后乳房的生理健康状况。本研究旨在探究荷斯坦牛产后前60 d患SCM次数对各泌乳月体细胞评分（somatic cell score,SCS）的影响,以期为牧场及时采取相关措施进行隐性乳房炎防控提供科学依据。本研究收集江苏地区12个奶牛场2017—2019年荷斯坦牛365 105条DHI测定日记录,并利用一般线性模型分析荷斯坦牛产后前60 d患SCM次数对不同胎次、牧场规模、测定季节、产犊季节各泌乳月SCS的影响。结果表明,荷斯坦牛产后前60 d患SCM次数对不同胎次、牧场规模、测定季节和产犊季节各泌乳月SCS均有极显著影响（P<0.01）;5胎及以上和夏季产犊的荷斯坦牛产后前60 d患SCM的比例较高;中小规模牧场和夏、秋季节产犊的荷斯坦牛各泌乳月SCS随产后前60 d患SCM次数的增加极显著增加（P<0.01）;随着泌乳月的增加,产后前60 d SCS与各泌乳月SCS的相关系数逐渐下降,头胎牛产后前60 d SCS与第3~7泌乳月SCS的相关系数最低,4胎牛较高;秋季产犊的荷斯坦牛产后前60 d SCS与第3~5泌乳月SCS相关系数均大于0.43,高于其他产犊季节。该结果有利于牧场根据奶牛产后前60 d患SCM次数乳对泌乳中后期SCS进行预测,从而指导牧场及时采取相关措施进行隐性乳房炎防控。     

Estimating the costs of rearing young dairy cattle in the Netherlands using a simulation model that accounts for uncertainty related to diseases

The costs of rearing young dairy cattle are a part of the cost of the price of milk, as rearing produces the future dairy cows. As most dairy farmers are not aware of the rearing costs, the rearing of dairy replacements often does not get the attention it deserves. Calculating the distribution of the rearing costs throughout the rearing process is difficult as the costs are correlated with biological processes, such as variation in growth rate and disease uncertainty. In this study, a calf level simulation model was built to estimate the rearing costs and their distribution from 2 weeks of age until first calving in the Netherlands. The uncertainties related to calf diseases (calf scours and bovine respiratory disease) were included, in which both the probabilities of disease and the effects of diseases (growth reduction) differ at different ages. In addition, growth was modeled stochastically and in a detailed manner using a two-phase growth function. The total cost of rearing young dairy cattle was estimated as €1567 per successfully reared heifer and varied between €1423 and €1715. Reducing the age of first calving by 1 month reduced the total cost between 2.6% and 5.7%. The difference in the average cost of rearing between heifers that calved at 24 months and those calving at 30 months was €400 per heifer reared. Average rearing costs were especially influenced by labor efficiency and cost of feed. The rearing costs of a heifer that experienced disease at least once (20% of the simulated heifers) were on average €95 higher than those of healthy heifers. Hence, for an individual diseased heifer, disease costs can be rather high, while the relative contribution to the average rearing cost for a standard Dutch dairy farm is low (approx. 3%). Overall, the model developed proved to be a useful tool to investigate the total cost of rearing young dairy cattle, providing insights to dairy farmers with respect to the cost-efficiency of their own rearing management.